A nurse is teaching a group of nursing students about antidysrhythmic medications. Which statement by a student indicates understanding of the teaching?

Antidysrhythmic medications are pharmacologically complex and carry a narrow therapeutic index. While they are designed to correct abnormal rhythms by altering ion channel conduction, this same mechanism can paradoxically interfere with the heart’s electrical stability, leading to proarrhythmic effects and increased clinical risk. A. This statement is correct. All antidysrhythmic drugs have the potential to be proarrhythmic, meaning they can induce new, sometimes more lethal arrhythmias or exacerbate the condition they were intended to treat. This is why many of these medications require initiation in a monitored hospital setting. B. This statement is incorrect. The use of these potent medications requires a clear clinical benefit that outweighs the significant risks. Administering such dangerous drugs without a clear understanding of the expected therapeutic outcome would be inconsistent with safe pharmacological practice and patient-centered care. C. Surprisingly, for many traditional antidysrhythmic drugs, there is a lack of evidence showing a reduction in long-term mortality. In some clinical trials, such as the CAST study, certain antidysrhythmics actually increased mortality rates, leading to a shift toward using non-pharmacological interventions like ICDs or ablation. D. This statement is incorrect. While these drugs do have noncardiac side effects (such as the pulmonary toxicity of amiodarone), their most dangerous and significant adverse effects are primarily cardiac. These include profound bradycardia, heart block, and the aforementioned proarrhythmic effects that directly impact hemodynamic stability.